BrightSpring Health Services, Inc. ( (BTSG) ) has released its Q3 earnings. Here is a breakdown of the information BrightSpring Health Services, Inc. presented to its investors.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
BrightSpring Health Services, Inc. is a prominent provider of home and community-based health services, focusing on complex populations with specialized and chronic care needs across the United States. The company operates in the healthcare sector, delivering integrated care solutions through various service lines, including pharmacy, home health care, and rehabilitation.
In its third-quarter 2025 earnings report, BrightSpring Health Services announced a significant increase in revenue and net income, along with an upward revision of its full-year revenue guidance. The company reported revenues of $3,334 million, marking a 28.2% increase from the previous year, and a net income of $37.5 million, a substantial improvement from a net loss in the same quarter of 2024.
Key financial highlights include a gross profit of $392 million, up 21.3% year-over-year, and an adjusted EBITDA of $160 million, reflecting a 37.2% increase. The company also completed a secondary offering and share repurchase, which closed in October 2025. BrightSpring’s strategic divestiture of its Community Living business is expected to close in the first quarter of 2026, aligning with its focus on core operations.
Looking ahead, BrightSpring has increased its 2025 revenue guidance, projecting growth between 24.1% and 27.1%, and reiterated its adjusted EBITDA guidance. The company remains committed to delivering high-quality, patient-centric care while leveraging its scale to enhance operational efficiencies and service delivery.
BrightSpring’s management expresses confidence in sustaining its growth trajectory into 2026, emphasizing the company’s dedication to executing its strategic goals and maintaining its leadership position in the healthcare sector.